Back to Search
Start Over
Relevance of Dermabacter hominis isolated from clinical samples, 2012-2016: a retrospective case series.
- Source :
-
Diagnostic microbiology and infectious disease [Diagn Microbiol Infect Dis] 2020 Oct; Vol. 98 (2), pp. 115118. Date of Electronic Publication: 2020 Jun 24. - Publication Year :
- 2020
-
Abstract
- We investigated the clinical relevance of Dermabacter hominis isolated from samples of 108 patients. Polymicrobial growth was evident in 88% of specimens. Isolation of D. hominis was of definitive or possible significance in only 14% of patients. Vancomycin remains the drug of choice given a penicillin resistance rate of 84%.<br /> (Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Subjects :
- Actinobacteria drug effects
Actinobacteria isolation & purification
Actinomycetales drug effects
Actinomycetales isolation & purification
Actinomycetales Infections drug therapy
Adult
Aged
Aged, 80 and over
Anti-Bacterial Agents therapeutic use
Bacterial Typing Techniques
DNA, Bacterial
Drug Resistance, Bacterial
Female
Humans
Male
Middle Aged
Penicillins pharmacology
Retrospective Studies
Vancomycin pharmacology
Actinobacteria classification
Actinomycetales classification
Actinomycetales Infections microbiology
Subjects
Details
- Language :
- English
- ISSN :
- 1879-0070
- Volume :
- 98
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Diagnostic microbiology and infectious disease
- Publication Type :
- Academic Journal
- Accession number :
- 32683204
- Full Text :
- https://doi.org/10.1016/j.diagmicrobio.2020.115118